Efficacy of bevacizumab-based treatment in early-onset treatment-naive metastatic colorectal cancer patients: An ARCAD database analysis

被引：0
|
作者：
Jin, Zhaohui
Dixon, Jesse G.
Hubbard, Joleen M.
Eng, Cathy
Lieu, Christopher Hanyoung
Fiskum, Jack
Saltz, Leonard B.
Hurwitz, Herbert I.
Venook, Alan P.
Schmoll, Hans-Joachim
Fuchs, Charles S.
Hecht, J. Randolph Randolph
Cremolini, Chiara
Diaz-Rubio, Eduardo
Punt, Cornelis J. A.
Tebbutt, Niall C.
Heinemann, Volker
Yoshino, Takayuki
De Gramont, Aimery
Shi, Qian
机构：
[1] Univ Iowa, Iowa City, IA 52242 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Rochester, MN USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[5] Univ Colorado, Ctr Canc, Aurora, CO USA
[6] Mem Sloan Kettering Canc Ctr, Dept Colorectal Oncol, 1275 York Ave, New York, NY 10021 USA
[7] Duke Univ, Sch Med, Durham, NC USA
[8] Univ Calif San Francisco, San Francisco, CA 94143 USA
[9] Martin Luther Univ Halle Wittenberg, Halle, Germany
[10] Yale Canc Ctr, New Haven, CT USA
[11] Smilow Canc Hosp, New Haven, CT USA
[12] UCLA, Los Angeles, CA USA
[13] Azienda Osped Univ, Pisana Ospedale Santa Chiara, Pisa, Italy
[14] Hosp Clin Univ San Carlos, Madrid, Spain
[15] Amsterdam UMC, Canc Ctr Amsterdam, Dept Med Oncol, Amsterdam, Netherlands
[16] Austin Hlth, Wellness & Res Ctr, Olivia Newton John Canc, Heidelberg, Vic, Australia
[17] Univ Hosp Munich, LMU Munich, Munich, Germany
[18] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[19] Franco British Inst, Levallois Perret, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
101
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Sex differences in efficacy and toxicity of first-line treatment of metastatic colorectal cancer (CRC): An analysis of 18,399 patients in the ARCAD database.
    Wagner, Anna Dorothea
    Rakez, Manel
    Chibaudel, Benoist
    Adams, Richard
    Zalcberg, John Raymond
    Saltz, Leonard B.
    Venook, Alan P.
    Schmoll, Hans-Joachim
    Douillard, Jean-Yves
    Tournigand, Christophe
    Heinemann, Volker
    Goldberg, Richard M.
    Hecht, J. Randolph
    Cremolini, Chiara
    Diaz-Rubio, Eduardo
    Grothey, Axel
    Shi, Qian
    De Gramont, Aimery
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer
    Prager, Gerald W.
    Braemswig, Kira H.
    Martel, Alexandra
    Unseld, Matthias
    Heinze, Georg
    Brodowicz, Thomas
    Scheithauer, Werner
    Kornek, Gabriela
    Zielinski, Christoph C.
    CANCER SCIENCE, 2014, 105 (08) : 996 - 1001
  • [23] Disparity of treatment-related adverse events and outcome in patients with early-onset metastatic colorectal cancer (mCRC).
    Meng, Lingbin
    Thapa, Ram
    Kim, Richard D.
    Laber, Damian A.
    Xie, Hao
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Efficacy of obesity in metastatic colorectal cancer patients treated with bevacizumab-based chemotherapy combinations: A Turkish Oncology Group Study
    Artac, M.
    Korkmaz, L.
    Coskun, H.
    Dane, F.
    Karabulut, B.
    Karaagac, M.
    Cabuk, D.
    Karabulut, S.
    Aykan, F.
    Doruk, H.
    Avci, N.
    Turhal, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [25] A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients
    Ogawa, Kohei
    Ueno, Takao
    Kato, Ken
    Nishitani, Hitoshi
    Akiyoshi, Kohei
    Iwasa, Satoru
    Nakajima, Takako Eguchi
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Hosokawa, Ayumu
    Sugiyama, Toshiro
    Shimada, Yasuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1020 - 1024
  • [26] A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients
    Kohei Ogawa
    Takao Ueno
    Ken Kato
    Hitoshi Nishitani
    Kohei Akiyoshi
    Satoru Iwasa
    Takako Eguchi Nakajima
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Ayumu Hosokawa
    Toshiro Sugiyama
    Yasuhiro Shimada
    International Journal of Clinical Oncology, 2013, 18 : 1020 - 1024
  • [27] Tumor characteristics and treatment in early-onset colorectal cancer.
    Burnett-Hartman, Andrea
    Powers, John D.
    Chubak, Jessica
    Corley, Douglas
    Ghai, Nirupa R.
    McMullen, Carmit K.
    Pawloski, Pamala A.
    Feiglelson, Heather S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [28] Safety and efficacy of sunitinib and FOLFIRI in combination in treatment-naive metastatic colorectal cancer (mCRC): a phase I study
    Vazquez, F.
    Carrato, A.
    Starling, N.
    Chau, I.
    Hill, P.
    Lechuga, M. J.
    Tursi, J.
    Chao, R.
    Cunningham, D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 255 - 256
  • [29] Survival analysis and prediction of early-onset colorectal cancer patients post-chemotherapy: an analysis based on the SEER database
    Zhiguo Tang
    Guojia Zhou
    Yu Xu
    Yinxu Zhang
    International Journal of Colorectal Disease, 40 (1)
  • [30] Bleeding after bevacizumab treatment in patients with metastatic colorectal cancer
    Cao, Dan
    Guo, Chun-hong
    Liu, Jie-wei
    Yang, Xi
    Li, Qiu
    TUMORI JOURNAL, 2015, 101 (01): : 46 - 51
12345